Qing Ye

ORCID: 0009-0004-5439-1892
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Hernia repair and management
  • Spine and Intervertebral Disc Pathology
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Esophageal Cancer Research and Treatment
  • Liver Disease and Transplantation
  • Diabetes Management and Education
  • Anesthesia and Pain Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Alcohol Consumption and Health Effects
  • Cancer-related gene regulation
  • Radiopharmaceutical Chemistry and Applications
  • Pelvic and Acetabular Injuries
  • Medical Imaging and Analysis
  • Advanced Algorithms and Applications
  • Vehicle Dynamics and Control Systems
  • Simulation and Modeling Applications

Tianjin Third Central Hospital
2018-2025

Tianjin Medical University
2018-2025

Fuzhou University
2025

Tianjin University
2025

Shanghai Jiao Tong University
2024

Nanjing Medical University
2023

Nanjing Municipal Center for Disease Control And Prevention
2023

Although pegylated interferon α-2b (PEG-IFN α-2b) therapy for chronic hepatitis B has received increasing attention, determining the optimal treatment course remains challenging. This research aimed to develop an efficient model predicting (IFN) course. Patients with B, undergoing PEG-IFN monotherapy or combined NAs (Nucleoside Analogs), were recruited from January 2018 December 2023 at Tianjin Third Central Hospital. All patients achieved surface antigen (HBsAg) clearance post-treatment....

10.3389/fimmu.2024.1528758 article EN cc-by Frontiers in Immunology 2025-01-10

Functional cure strategies based on interferon therapy for chronic hepatitis B (CHB) are gaining increasing attention among clinicians. However, studies investigating the duration of response after achieving HBsAg clearance with treatment limited. This study aims to explore patterns sustained following in patients treated pegylated alpha-2b (PegIFNα-2b) through long-term follow-up, providing guidance clinical practice. We collected data from CHB who achieved and were either PegIFNα-2b...

10.3389/fimmu.2025.1518048 article EN cc-by Frontiers in Immunology 2025-04-08

Abstract Introduction To investigate the association between alcohol drinking and glycemic management among adult patients with type 2 diabetes in regional China. Materials Methods In this cross‐sectional survey conducted Nanjing Municipality of China 2018, were randomly selected from urban rural communities. The outcome variable was status. explanatory measure drinking. Mixed‐effects regression models employed to estimate odds ratios (ORs) 95% confidence interval (95% CI) for examining...

10.1111/jdi.14108 article EN cc-by-nc-nd Journal of Diabetes Investigation 2023-11-20

Objective: To compare the differences in prevalence of mild micro-hepatic encephalopathy (MHE) among patients with cirrhosis by using psychometric hepatic score (PHES) and Stroop smartphone application (Encephal App) test. Methods: This prospective, multi-center, real-world study was initiated National Clinical Medical Research Center for Infectious Diseases Portal Hypertension Alliance registered International ClinicalTrials.gov (NCT05140837). 354 cases were enrolled 19 hospitals across...

10.3760/cma.j.cn501113-20220602-00298 article EN PubMed 2023-09-20

<title>Abstract</title> <bold>Objective: </bold>Although multimodality treatment, including chemoradiotherapy and surgery has significantly improved the prognosis of patients with esophageal squamous cell carcinoma (ESCC), a valid predictor is crucial for individualized treatment. As acyl-CoA synthetase long-chain family member 4 (ACLS4) glutathione peroxidase (GPX4) are key genes radiation responses constituents ferroptosis signaling pathway, present study adopted ACSL4 GPX4 protein...

10.21203/rs.3.rs-4300021/v1 preprint EN cc-by Research Square (Research Square) 2024-04-29

Objective: To study the nutritional status and energy metabolic characteristics of patients with nonalcoholic fatty liver disease (NAFLD), to provide evidence for clinical evaluation intervention. Methods: A total 359 NAFLD diagnosed on ultrasound from June 2015 March 2017 were selected as subjects divided into mild, moderate severe group 50 healthy control group. The changes ICW, ECW, body fat, skeletal muscle, protein visceral fat area (VFA) controls analyzed by using composition analyzer....

10.3760/cma.j.issn.1007-3418.2018.07.009 article EN PubMed 2018-07-20
Coming Soon ...